See also this year's filing and all EDGAR filings for this company.
PDF Report 0001133416_2023_GALECTIN_THERAPEUTICS_INC.pdf
Logs
Graph
Absolute values for 0001133416, GALECTIN THERAPEUTICS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 20,552,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 733,000 |
| 4 | LiabilitiesCurrent | 13,012,000 |
| 5 | LiabilitiesNoncurrent | 66,000 |
| 6 | remainder_Liabilities | 40,401,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,615,000 |
| 9 | ResearchAndDevelopmentExpense | 31,737,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -424,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 21,285,000 |
| 1 | Liabilities | 53,479,000 |
| 2 | Expenses | 38,352,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -32,194,000 |
| 5 | NetIncome | -38,776,000 |
| 6 | ComprehensiveNetIncome | -38,776,000 |
| 7 | BaseVar | 56,770,000 |
| 8 | EconomicCapitalRatio | -2.52 |